(Q30411523)

18 August 2017

Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study (English)

1 reference

multicenter clinical trial

18 August 2017

0 references

1 reference

Brandon Foreman

2

0 references

James N Brenton

James N Brenton

4

0 references

Cecil Hahn

Cecil D Hahn

17

0 references

Howard P Goodkin

Howard P Goodkin

18

0 references

Tobias Loddenkemper

Tobias Loddenkemper

16

0 references

Jerzy P Szaflarski

15

Jerzy P Szaflarski

1 reference

18 August 2017

Lawrence James Hirsch

20

Lawrence J Hirsch

1 reference

18 August 2017

Nicolas Gaspard

1

1 reference

18 August 2017

Lilith M Judd

3

1 reference

18 August 2017

Barnett R Nathan

5

1 reference

18 August 2017

Blathnaid M McCoy

6

1 reference

18 August 2017

Ali Al-Otaibi

7

1 reference

18 August 2017

Ronan Kilbride

8

1 reference

18 August 2017

Ivan Sánchez Fernández

9

1 reference

18 August 2017

Lucy Mendoza

10

1 reference

18 August 2017

Sophie Samuel

11

1 reference

18 August 2017

Asma Zakaria

12

1 reference

18 August 2017

Giridhar P Kalamangalam

13

1 reference

18 August 2017

Benjamin Legros

14

1 reference

18 August 2017

Jan Claassen

19

1 reference

18 August 2017

Suzette M Laroche

21

1 reference

18 August 2017

12 June 2013

1 reference

18 August 2017

1 reference

18 August 2017

54

1 reference

18 August 2017

8

1 reference

18 August 2017

1498-1503

1 reference

Ketamine use in the treatment of refractory status epilepticus

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731413

Efficacy and safety of ketamine in refractory status epilepticus in children

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731413

Guidelines for the evaluation and management of status epilepticus

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731413

A randomized trial for the treatment of refractory status epilepticus.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731413

The impact of diazepam's discovery on the treatment and understanding of status epilepticus

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731413

Cryptogenic New Onset Refractory Status Epilepticus (NORSE) in adults-Infectious or not?

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731413

Ketamine and neurotoxicity: clinical perspectives and implications for emergency medicine

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731413

Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731413

Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731413

Ketamine controls prolonged status epilepticus

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731413

Electrographic tachyphylaxis to etomidate and ketamine used for refractory status epilepticus controlled with isoflurane.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731413

Letter: Ketamine-induced acidosis, fever, and creatine-kinase rise

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731413

Refractory metabolic acidosis as a complication of high-dose midazolam infusion for pediatric status epilepticus

20 June 2018

1 reference

Pharmacokinetics and haemodynamics of ketamine in intensive care patients with brain or spinal cord injury

21 January 2018

1 reference

A "malignant" variant of status epilepticus.

21 January 2018

1 reference

Terminating prolonged refractory status epilepticus using ketamine

21 January 2018

1 reference

Early ketamine to treat refractory status epilepticus.

21 January 2018

1 reference

Refractory status epilepticus: frequency, risk factors, and impact on outcome

21 January 2018

1 reference

N-methyl-D-asparate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat.

21 January 2018

1 reference

Refractory status epilepticus: a prospective observational study

21 January 2018

1 reference

Ketamine successfully terminates malignant status epilepticus

21 January 2018

1 reference

Refractory status epilepticus: response to ketamine.

21 January 2018

1 reference

Ketamine for refractory status epilepticus: a case of possible ketamine-induced neurotoxicity

21 January 2018

1 reference

The intensive care treatment of convulsive status epilepticus in the UK. Results of a national survey and recommendations.

21 January 2018

1 reference

Ketamine does not increase cerebral blood flow velocity or intracranial pressure during isoflurane/nitrous oxide anesthesia in patients undergoing craniotomy.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731413

26 November 2018

Identifiers

DOI

10.1111/EPI.12247

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

23758557

1 reference